Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03153982
Title Ruxolitinib in Operable Head and Neck Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field